Zhitong Finance App News, Jinhai Medical Technology (02225) issued an announcement. On November 6, 2026, the Company was notified by Mr. Chen Guobao (Mr. Chen), Chairman and Executive Director of the Company, and Baolai International Limited (Baolai, the controlling shareholder of the Company and wholly owned by Mr. Chen). On November 6, 2026, Baolai (as the seller) and Mr. Yang Fukang (Mr. Yang) (the buyer) sold 1,057 million shares (shares) of the Company's issued shares (shares) to Mr. Yang on the date of this announcement) Signing up Purchase and sale agreement (the agreement) (the matter of sale). The sale was completed after the agreement was signed. After all reasonable inquiries have been made by the directors of the Company, to their knowledge, knowledge and belief, the buyer is a third party independent of Bora, the Group, or any director, chief executive or major shareholder of the Group, or any of their respective contacts and not acting in agreement with them.
After the sale is completed, the number of shares held by Bora will be reduced from 2.53 billion shares (accounting for about 47.52% of the total issued share capital of the Company on the date of this announcement) to 1,472.5 billion shares (accounting for about 27.66% of the total issued share capital of the Company on the date of this announcement). Following the completion of the sale, Bora will cease to be the controlling shareholder of the Company; and Mr. Yang will become the main shareholder of the Company, holding approximately 19.86% of the total issued share capital of the Company on the date of this announcement.
The Company anticipates that the sale will not have any significant adverse impact on the Company's business operations and financial position.